Related Funds
Fund Name | Location |
Amatil X Ventures | Australia, New South Wales, North Sydney |
Bio-sight Capital | Ibaraki, Japan, Osaka Prefecture |
CenturyPartners | Detroit, Michigan, United States |
Chengdu Zhengjian | Chengdu, China, Sichuan |
Ennovent | Austria, Vienna |
GameStop Digital Ventures | Grapevine, Texas, United States |
Gates Frontier fund | - |
GMH Ventures | Newtown Square, Pennsylvania, United States |
Growth Catalyst Partners | Chicago, Illinois, United States |
Mavrik | - |
mortonsgroup | Nebraska, United States, Virginia |
Nutrien Ag Solutions | Colorado, Loveland, United States |
Pawan Munjal Family Trust | - |
Qwest | Colorado, Denver, United States |
Spotlight Ventures | Kansas City, Missouri, United States |
Sydes | - |
The Royal Trust | Canada, Montréal, Quebec |
Ubon Partners | Norway, Oslo |
Yongfeng Machinery | China, Jimo, Shandong |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Doma Biopharmaceutical | $146M | 02 Jun 2022 | Kagoshima, Kagoshima Prefecture, Japan | ||
GeneQuantum Healthcare | 18 May 2021 | Dongcheng District, Beijing, China | |||
SEG Smartechs | $463K | 01 May 2001 | Longgang District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Doma Biopharmaceutical | $146M | 02 Jun 2022 | Kagoshima, Kagoshima Prefecture, Japan | ||
GeneQuantum Healthcare | 18 May 2021 | Dongcheng District, Beijing, China | |||
SEG Smartechs | $463K | 01 May 2001 | Longgang District, Guangdong Province, China |